Family Medicine Doctors in Benkelman, NE Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Carol S Hofman, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1313 N Cheyenne St, Benkelman, NE 69021 Phone: 308-423-2204 Fax: 308-423-5691 |
Dr. Lori L Stonehocker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1313 N Cheyenne St, Benkelman, NE 69021 Phone: 308-423-2151 Fax: 308-423-2217 |
Mrs. Tammi Cawthra, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1313 N Cheyenne St, Benkelman, NE 69021 Phone: 308-423-2204 Fax: 308-423-5691 |
 Dr. Jose Ramon Garcia Sr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1313 N Cheyenne Street, Box 626, Benkelman, NE 69021 Phone: 308-423-2204 |
News Archive
National survey shows 60% of U.S. adults not familiar with sepsis
Sixty percent of U.S. adults are not familiar with sepsis, despite the fact that more than 200,000 Americans die from it every year, making sepsis one of the leading causes of death in the nation. Lack of awareness is even higher among adults over age 65, who are at greater risk of sepsis, according to a new national survey sponsored by The Feinstein Institute for Medical Research in Manhasset, NY, part of the North Shore–LIJ Health System.
Also in global health news: Somali IDPS; MDR-TB elimination; Chagas; Zimbabwe disease, hunger
At the conclusion of a week-long visit to the region, Walter Kalin, a top U.N. human-rights official "says the international community is failing in its duty to internally displaced persons in Somalia. More than 1.5 million people in Somalia are believed to be IDPs," VOA News reports (Boswell, 10/21).
COVID-19 vaccination and lactation
A new study evaluates the presence of antibodies in breastmilk and the immune responses of lactating women after vaccination of the COVID-19 vaccine.
Lymphocyte clue to multiple sclerosis drug response
Patients with rapid recovery of CD4-positive T cells after alemtuzumab treatment for multiple sclerosis are at risk for disease progression or relapse, research suggests.
› Verified 1 days ago